Literature DB >> 30510044

High-strength opioid formulations: the case for a ministerial recall.

Matthew Herder1, David Juurlink2.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 30510044      PMCID: PMC6258213          DOI: 10.1503/cmaj.181289

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Trends in high-dose opioid prescribing in Canada.

Authors:  Tara Gomes; Muhammad M Mamdani; J Michael Paterson; Irfan A Dhalla; David N Juurlink
Journal:  Can Fam Physician       Date:  2014-09       Impact factor: 3.275

Review 2.  Rethinking "doing well" on chronic opioid therapy.

Authors:  David N Juurlink
Journal:  CMAJ       Date:  2017-10-02       Impact factor: 8.262

3.  Association between opioid prescribing patterns and opioid overdose-related deaths.

Authors:  Amy S B Bohnert; Marcia Valenstein; Matthew J Bair; Dara Ganoczy; John F McCarthy; Mark A Ilgen; Frederic C Blow
Journal:  JAMA       Date:  2011-04-06       Impact factor: 56.272

4.  CANADIAN THALIDOMIDE EXPERIENCE.

Authors:  J F WEBB
Journal:  Can Med Assoc J       Date:  1963-11-09       Impact factor: 8.262

5.  Guideline for opioid therapy and chronic noncancer pain.

Authors:  Jason W Busse; Samantha Craigie; David N Juurlink; D Norman Buckley; Li Wang; Rachel J Couban; Thomas Agoritsas; Elie A Akl; Alonso Carrasco-Labra; Lynn Cooper; Chris Cull; Bruno R da Costa; Joseph W Frank; Gus Grant; Alfonso Iorio; Navindra Persaud; Sol Stern; Peter Tugwell; Per Olav Vandvik; Gordon H Guyatt
Journal:  CMAJ       Date:  2017-05-08       Impact factor: 8.262

6.  Trends in opioid use and dosing among socio-economically disadvantaged patients.

Authors:  Tara Gomes; David N Juurlink; Irfan A Dhalla; Angela Mailis-Gagnon; J Michael Paterson; Muhammad M Mamdani
Journal:  Open Med       Date:  2011-01-25

7.  Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.

Authors:  Tara Gomes; Wayne Khuu; Diana Martins; Mina Tadrous; Muhammad M Mamdani; J Michael Paterson; David N Juurlink
Journal:  BMJ       Date:  2018-08-29
  7 in total
  6 in total

1.  Flawed arguments in this commentary.

Authors:  Marvin Ross
Journal:  CMAJ       Date:  2019-03-18       Impact factor: 8.262

2.  Consider the economic burden for patients.

Authors:  Stanley Lofsky
Journal:  CMAJ       Date:  2019-03-18       Impact factor: 8.262

3.  Recalling high-strength opioid formulations would cause harm.

Authors:  Kevin Wade
Journal:  CMAJ       Date:  2019-03-04       Impact factor: 8.262

4.  Muddling Health Canada's powers and diluting accountability.

Authors:  Pamela M Forward
Journal:  CMAJ       Date:  2019-03-04       Impact factor: 8.262

5.  Opioid Wisely.

Authors:  Leonie Herx
Journal:  CMAJ       Date:  2019-03-04       Impact factor: 8.262

6.  A recall of high-strength opioids would be harmful.

Authors:  Robert A Strang
Journal:  CMAJ       Date:  2019-03-04       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.